Providing leading edge diagnostic solutions in oncology
AccuGenomics provides gene expression tests that accurately diagnose, monitor and inform cancer treatment. AccuGenomics' technologies generate the most comprehensive test results which ensure confidence in clinical decisions and provide credible and reliable gene expression data to the medical community.
Strong portfolio
standardized Proprietary gene expression Tests:
Unique know-how
Market
molecular diagnostic tests have a high barrier to competitive entry due to FDA initiatives in molecular diagnostics: